|
ADHD 201 is designed for clinicians seeking to deepen their understanding of ADHD across the lifespan and refine evidence-based treatment strategies. This session brings together leading experts to address emerging science, evolving clinical challenges, and practical decision-making in ADHD care.
Dr. Maggie Sibley will present advances in psychosocial treatments for adolescents with ADHD, focusing on developmentally informed, evidence-based interventions. Dr. Ann Childress will discuss rational combination therapies, emphasizing thoughtful, individualized treatment planning for complex presentations. Dr. Brooke Molina will examine ADHD and the aging brain, highlighting longitudinal findings and implications for adult and later-life management. Dr. Greg Mattingly will then explore contemporary issues in ADHD prescribing, challenging traditional approaches and offering strategies to optimize safety and effectiveness. ADHD 201 will then conclude with an interactive Q & A discussion with our APSARD members.
Together, these presentations will provide a comprehensive, clinically relevant update for practitioners managing ADHD across developmental stages and levels of complexity.
Register today for the full conference which includes this session!
|